We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TI
276
DELISTED
Telecom Italia
TI
| $11.4M | 0.06% |
906,092
-27,238
| -3% | -$337K |
|
277
CenterPoint Energy
CNP
$26.6B
| $11.4M | 0.06% |
447,527
-1,131,948
| -72% | -$27.4M |
|
|
MGLN
278
DELISTED
Magellan Health Services, Inc.
MGLN
| $11.4M | 0.06% |
182,757
+10,285
| +6% | +$604K |
|
279
UGI
UGI
$7.44B
| $11.2M | 0.06% |
+334,026
| New | +$10.6M |
|
280
Sally Beauty Holdings
SBH
$1.52B
| $10.9M | 0.06% |
434,900
-308,351
| -41% | -$7.96M |
|
|
UIL
281
DELISTED
UIL HOLDINGS
UIL
| $10.8M | 0.06% |
279,846
+166,897
| +148% | +$6.12M |
|
282
Entergy
ETR
$49.4B
| $10.8M | 0.06% |
263,830
-209,512
| -44% | -$7.81M |
|
|
CAM
283
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $10.8M | 0.06% |
+159,381
| New | +$10.3M |
|
|
OVTI
284
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $10.8M | 0.06% |
489,638
+23,915
| +5% | +$487K |
|
285
Snap-on
SNA
$21.4B
| $10.8M | 0.06% |
+90,753
| New | +$10.5M |
|
286
Jack Henry & Associates
JKHY
$11.1B
| $10.7M | 0.06% |
180,459
+10,115
| +6% | +$577K |
|
287
CVS Health
CVS
$123B
| $10.7M | 0.06% |
142,102
-976,266
| -87% | -$73.8M |
|
|
DEG
288
DELISTED
ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS
DEG
| $10.7M | 0.05% |
633,622
-248,518
| -28% | -$4.4M |
|
|
RFP
289
DELISTED
Resolute Forest Products Inc.
RFP
| $10.7M | 0.05% |
635,100
-229,123
| -27% | -$3.79M |
|
290
Jones Lang LaSalle
JLL
$16.7B
| $10.6M | 0.05% |
84,153
+59,241
| +238% | +$7.14M |
|
291
Citigroup
C
$226B
| $10.6M | 0.05% |
225,064
+219,118
| +3,685% | +$10.4M |
|
292
iShares Russell 2000 ETF
IWM
$82.3B
| $10.5M | 0.05% |
88,245
+3,793
| +4% | +$431K |
|
293
Cal-Maine
CALM
$3.96B
| $10.2M | 0.05% |
274,878
+52,134
| +23% | +$1.71M |
|
294
Brookfield
BN
$108B
| $10.2M | 0.05% |
+986,608
| New | +$9.87M |
|
295
Omnicell
OMCL
$1.65B
| $10.2M | 0.05% |
354,842
-24,035
| -6% | -$649K |
|
296
Camden Property Trust
CPT
$11B
| $10.1M | 0.05% |
+142,579
| New | +$9.91M |
|
297
Dorman Products
DORM
$4.12B
| $10.1M | 0.05% |
205,001
+20,445
| +11% | +$1.12M |
|
298
Usana Health Sciences
USNA
$265M
| $10.1M | 0.05% |
257,782
-38,484
| -13% | -$1.43M |
|
299
Petrobras
PBR
$120B
| $10.1M | 0.05% |
687,252
+655,880
| +2,091% | +$9.55M |
|
300
Everest Group
EG
$14.2B
| $10M | 0.05% |
+62,509
| New | +$9.89M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.